Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) General Information

Description

The macrophage assets for the treatment of cancer and liver fibrosis located in Philadelphia, Pennsylvania. The assets consist of macrophage and monocyte engineering technologies for in vivo engineered myeloid cell therapies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Philadelphia, PA
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Acquirer
United Immunity
Corporate Office
  • Philadelphia, PA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis)‘s full profile, request access.

Request a free trial

Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis)‘s full profile, request access.

Request a free trial

Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) FAQs

  • Where is Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) headquartered?

    Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) is headquartered in Philadelphia, PA.

  • What industry is Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) in?

    Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis)’s primary industry is Buildings and Property.

  • Is Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) a private or public company?

    Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) is a Private company.

  • What is Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis)’s current revenue?

    The current revenue for Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) is .

  • Who are Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis)’s investors?

    Carisma Therapeutics has invested in Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis).

  • When was Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) acquired?

    Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) was acquired on 21-May-2026.

  • Who acquired Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis)?

    Carisma Therapeutics (Macrophage Assets for the Treatment of Cancer and Liver Fibrosis) was acquired by United Immunity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process